HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio M Lacy Selected Research

Glucose Intolerance

12/2006GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio M Lacy Research Topics

Disease

7Weight Loss (Weight Reduction)
01/2017 - 07/2004
6Neoplasms (Cancer)
01/2017 - 06/2002
5Obesity
01/2017 - 06/2006
4Rectal Neoplasms (Rectal Cancer)
01/2019 - 03/2013
4Type 2 Diabetes Mellitus (MODY)
10/2017 - 12/2006
4Colonic Neoplasms (Colon Cancer)
07/2008 - 06/2002
3Body Weight (Weight, Body)
06/2012 - 07/2004
3Pain (Aches)
04/2011 - 08/2007
2Neoplasm Metastasis (Metastasis)
01/2022 - 03/2013
2Intraoperative Complications
08/2015 - 09/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 06/2006
2Morbid Obesity
06/2012 - 05/2009
2Insulin Resistance
03/2009 - 07/2004
2Colorectal Neoplasms (Colorectal Cancer)
03/2007 - 01/2006
1Esophageal Achalasia (Megaesophagus)
01/2019
1Hyperglycemia
01/2017
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2016
1Ulcerative Colitis
11/2015
1Abdominal Obesity
02/2014
1Thrombophilia
02/2014
1Ileus
09/2013
1Albuminuria
06/2013
1Hypertension (High Blood Pressure)
06/2013
1Dehydration (Water Stress)
01/2013
1Pathologic Constriction (Stenosis)
03/2011
1Incisional Hernia
08/2007
1Glucose Intolerance
12/2006
1Shock
11/2006
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
11/2006
1Septic Shock (Toxic Shock Syndrome)
11/2006
1Fibrosis (Cirrhosis)
11/2006
1Cardiovascular Diseases (Cardiovascular Disease)
06/2006
1Body Weight Changes
07/2004
1Circulating Neoplastic Cells
03/2003

Drug/Important Bio-Agent (IBA)

4Glucose (Dextrose)FDA LinkGeneric
06/2013 - 12/2006
3Biomarkers (Surrogate Marker)IBA
01/2018 - 02/2014
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
12/2015 - 09/2014
2Glucagon-Like Peptide 1 (GLP 1)IBA
03/2009 - 12/2006
2Carcinoembryonic AntigenIBA
01/2006 - 03/2003
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022
1FibrinIBA
12/2016
1Fibrinogen (Factor I)FDA Link
02/2014
1Adenosine Triphosphate (ATP)IBA
01/2014
1AlbuminsIBA
06/2013
1CreatinineIBA
06/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2009
1Peptide YYIBA
02/2008
1Analgesics (Analgesic Drugs)IBA
08/2007
1Hydrocortisone (Cortisol)FDA LinkGeneric
11/2006
1C 76 (C76)IBA
11/2006
1SteroidsIBA
11/2006
1AdiponectinIBA
06/2006
1Adiponectin ReceptorsIBA
06/2006
1Insulin-Like Growth Factor Binding ProteinsIBA
08/2005
1Interleukin-12 (IL 12)IBA
08/2005
1Matrix Metalloproteinases (MMPs)IBA
08/2005
1GhrelinIBA
07/2004
1Messenger RNA (mRNA)IBA
03/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2003

Therapy/Procedure

7Gastric Bypass (Roux-en-Y Gastric Bypass)
12/2015 - 07/2004
5Bariatric Surgery
10/2017 - 03/2011
5Colectomy
07/2008 - 06/2002
4Length of Stay
09/2013 - 06/2002
3Operative Time
11/2015 - 09/2013
2Therapeutics
01/2017 - 03/2007
2Gastrectomy
05/2012 - 05/2009
1Traction
01/2019
1Cholecystectomy
01/2019
1Myotomy
01/2019
1Neoadjuvant Therapy
01/2016
1Proctectomy
11/2015
1Radiotherapy
03/2013
1Ileostomy
01/2013
1Analgesia
01/2009
1Operative Surgical Procedures
03/2003